METTL3 blocked the progression of diabetic retinopathy through m6A-modified SOX2
We aimed to explore the regulatory effects of methyltransferase-like 3 (METTL3) on diabetic retinopathy (DR) by regulating the m6A modification of SOX2 mRNA and elucidating the underlying molecular mechanism. The DR model was established by stimulating human retinal endothelial cells (HRECs) with hi...
Saved in:
| Main Authors: | Chen Xiujuan, Ling Qipeng, Xu Jie, Ye Yunyao, Dong Lili |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-07-01
|
| Series: | Open Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/med-2025-1191 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
METTL14 modulates the progression and ferroptosis of colitis by regulating the stability of m6A-modified GPX4
by: Yuhua Chen, et al.
Published: (2025-02-01) -
The role of SOX transcription factors in prostate cancer: Focusing on SOX2
by: Guotu Du, et al.
Published: (2025-11-01) -
METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells
by: Bo Tang, et al.
Published: (2025-08-01) -
METTL3 facilitates the progression of cervical cancer by m6A modification-mediated up-regulation of NEK2
by: Yilin Guo, et al.
Published: (2024-10-01) -
DNMT1 blocks SOX21-repressed CKS2 transcription to promote gastric cancer progression
by: Jie Wei, et al.
Published: (2025-07-01)